Yu Saiyuu, Tanabe Teruyo, Dezawa Mari, Ishikawa Hiroto, Yoshimura Nagahisa
Department of Ophthalmology and Visual Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Biochem Biophys Res Commun. 2006 Jun 16;344(4):1071-9. doi: 10.1016/j.bbrc.2006.03.231. Epub 2006 Apr 27.
We investigated if bone marrow stromal cells (BMSCs) transplanted into the vitreous body of a glaucoma model eye could be integrated in the host retina and also whether they could rescue the retinal ganglion cells (RGCs) from death induced by the elevated intraocular pressure. Glaucoma was induced in the right eye of adult Wistar rats by ligating the episcleral veins. The GFP-expressing BMSCs (GFP-BMSCs) were injected into the vitreous body of both the control and the glaucomatous eyes. After transplantation, GFP-BMSCs were mostly present along with the inner limiting membrane and only a few cells were integrated into the ganglion cell layer. At 2 or 4 weeks after transplantation, GFP-BMSCs were observed to express various trophic factors. The BMSCs injected glaucoma model eyes showed less reduction in the number of RGCs compared to the glaucomatous eyes with PBS injection. This study suggests that BMSC transplantation may be worthy as a neuroprotective tool to treat glaucoma.
我们研究了移植到青光眼模型眼玻璃体内的骨髓基质细胞(BMSCs)是否能整合到宿主视网膜中,以及它们是否能挽救因眼压升高而死亡的视网膜神经节细胞(RGCs)。通过结扎成年Wistar大鼠右眼的巩膜静脉诱导青光眼。将表达绿色荧光蛋白的骨髓基质细胞(GFP-BMSCs)注入对照眼和青光眼眼中。移植后,GFP-BMSCs大多与内界膜一起存在,只有少数细胞整合到神经节细胞层。移植后2或4周,观察到GFP-BMSCs表达多种营养因子。与注射PBS的青光眼眼相比,注射BMSCs的青光眼模型眼的RGCs数量减少较少。这项研究表明,BMSC移植作为一种治疗青光眼的神经保护工具可能是值得的。